| Year |
Citation |
Score |
| 2018 |
Flower VA, Barratt SL, Ward S, Pauling JD. The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis. Current Rheumatology Reviews. PMID 30091416 DOI: 10.2174/1573397114666180809121005 |
0.594 |
|
| 2018 |
Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, Barratt S, Machado MJ, Donaldson LF, Harper SJ, Peiris-Pages M, Tortonese DJ, Oltean S, Foster RR. Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Comprehensive Physiology. 8: 955-979. PMID 29978898 DOI: 10.1002/Cphy.C170015 |
0.501 |
|
| 2018 |
Barratt SL, Flower VA, Pauling JD, Millar AB. VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease. International Journal of Molecular Sciences. 19. PMID 29695053 DOI: 10.3390/ijms19051269 |
0.512 |
|
| 2018 |
Barratt SL, Blythe T, Ourradi K, Jarrett C, Welsh GI, Bates DO, Millar AB. Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF). Respiratory Research. 19: 9. PMID 29334947 DOI: 10.1186/S12931-017-0711-X |
0.674 |
|
| 2018 |
Dixon C, Viner J, Medford A, Gunawardena H, Barratt S, Adamali H. P230 The lung clearance index in adults with connective tissue disease – a pilot study in rheumatoid arthritis Thorax. 73. DOI: 10.1136/Thorax-2018-212555.387 |
0.308 |
|
| 2017 |
Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB. Differential Expression of VEGF-Axxx Isoforms is Critical for Development of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 28661183 DOI: 10.1164/Rccm.201603-0568Oc |
0.716 |
|
| 2017 |
Ourradi K, Blythe T, Jarrett C, Barratt SL, Welsh GI, Millar AB. VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells. Respiratory Research. 18: 116. PMID 28578669 DOI: 10.1186/s12931-017-0602-1 |
0.569 |
|
| 2015 |
Barratt S, Blythe T, Jarrett C, Ourradi K, Welsh G, Scotton C, Bates D, Millar A. S64 Alveolar epithelial type II cell expression of VEGF-Axxxa is critical for development of Idiopathic Pulmonary Fibrosis (IPF): an anti-fibrotic role for VEGF-Axxxb anti-angiogenic isoforms? Thorax. 70: A38.2-A39. DOI: 10.1136/Thoraxjnl-2015-207770.70 |
0.705 |
|
| 2014 |
Barratt S, Millar A. Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis. Qjm : Monthly Journal of the Association of Physicians. 107: 515-9. PMID 24453283 DOI: 10.1093/Qjmed/Hcu012 |
0.466 |
|
| 2014 |
Barratt S, Blythe T, Jarrett C, Welsh G, Ourradi K, Scotton C, Bates D, Millar A. S137 Vascular Endothelial Growth Factor (vegf) Expression In The Ipf Lung – A Role For Anti-angiogenic Isoforms? Thorax. 69. DOI: 10.1136/Thoraxjnl-2014-206260.143 |
0.708 |
|
| 2013 |
Barratt S, Medford AR, Millar AB. Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome. Respiration; International Review of Thoracic Diseases. 87: 329-42. PMID 24356493 DOI: 10.1159/000356034 |
0.524 |
|
| 2013 |
Bates DO, Mavrou A, Qiu Y, Carter JG, Hamdollah-Zadeh M, Barratt S, Gammons MV, Millar AB, Salmon AH, Oltean S, Harper SJ. Detection of VEGF-A(xxx)b isoforms in human tissues. Plos One. 8: e68399. PMID 23935865 DOI: 10.1371/Journal.Pone.0068399 |
0.633 |
|
| 2013 |
Barratt S, Blythe T, Jarrett C, Ourradi K, Maher T, Welsh G, Bates D, Millar A. P141 Differential expression of conventional and inhibitory VEGFA isoforms in normal and fibrotic fibroblasts–a potential role in IPF pathogenesis? Thorax. 68: A139.2-A140. DOI: 10.1136/Thoraxjnl-2013-204457.291 |
0.703 |
|
| 2013 |
Ourradi K, Jarrett C, Blythe T, Barratt S, Welsh G, Millar A. T2 VEGF signalling:differences in isoforms? Thorax. 68. DOI: 10.1136/Thoraxjnl-2013-204457.2 |
0.624 |
|
| 2012 |
Barratt S, Jarrett C, Blythe T, Welsh G, Maher T, Bates D, Millar A. S68 Bioavailability of VEGF in Idiopathic Pulmonary Fibrosis Thorax. 67: A34.2-A34. DOI: 10.1136/Thoraxjnl-2012-202678.074 |
0.708 |
|
| 2012 |
Ourradi K, Jarrett C, Blythe T, Barratt S, Welsh G, Millar A. S56 Unravelling VEGF165 Signalling in the Lung Thorax. 67. DOI: 10.1136/Thoraxjnl-2012-202678.062 |
0.602 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Barratt S, Iftikar H, McMillan M, Edey A, Adamali H, Gunawardena H. S146 Characterisation of anti-synthetase syndrome (ASS), initially presenting to respiratory services as interstitial lung disease (ILD) of unknown cause Thorax. DOI: 10.1136/Thorax-2018-212555.152 |
0.271 |
|
| 2017 |
Barratt S, Shaw J, Jones R, Adamali H, Cliff I, Clayton N, Mustfa N, Stone H, Chaudhuri N. P157 Can baseline physiological tests help predict the outcome of hypoxic challenge testing (hct) in interstitial lung disease (ild) Thorax. 72. DOI: 10.1136/Thoraxjnl-2017-210983.299 |
0.262 |
|
| 2018 |
Barratt S, Adamali H, Creamer A, Duckworth A, Fallon J, Gibbons M, Gooptu B, Nancarrow T, Pepperell J, Spiers A, Stone R, Wollerton R, Woodhead F, Scotton C. P163 A multicentre retrospective cohort comparison of aetiology and survival in patients with chronic hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Thorax. 73. DOI: 10.1136/Thorax-2018-212555.321 |
0.261 |
|
| 2019 |
Barratt S, Adamali H, Creamer A, Duckworth A, Wollerton R, Fallon J, Gibbons M, Gooptu B, Fidan S, Nancarrow T, Pepperell J, Stone R, Woodhead F, Scotton C. S85 Analysis of blood cell counts as predictors of survival in patients with hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis in a multicentre retrospective cohort Thorax. 74. DOI: 10.1136/Thorax-2019-Btsabstracts2019.91 |
0.261 |
|
| 2018 |
Barratt S, Pratt D, Chung A, Ridley C, Hewlett B, Towers L, Edey A, Gunawardena H, Adamali H. P156 The development of an interstitial lung disease (ILD) electronic dashboard to drive quality improvement Thorax. 73. DOI: 10.1136/Thorax-2018-212555.314 |
0.254 |
|
| 2018 |
Yates H, Adamali HI, Maskell N, Barratt S, Sharp C. Visual analogue scales for interstitial lung disease: a prospective validation study. Qjm : Monthly Journal of the Association of Physicians. PMID 29788503 DOI: 10.1093/Qjmed/Hcy102 |
0.248 |
|
| 2019 |
Davis R, Barratt S, Viner J, Dixon C, Morley A, Adamali H, Maskell N. P5 The use of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis: feasibility and correlation with quality of life measures Thorax. 74. DOI: 10.1136/Thorax-2019-Btsabstracts2019.148 |
0.248 |
|
| 2019 |
Hyams C, Hettle D, Adamali H, Barratt S. P54 Predicting outcomes of patients hospitalised with an acute respiratory deterioration of idiopathic pulmonary fibrosis Thorax. 74. DOI: 10.1136/Thorax-2019-Btsabstracts2019.197 |
0.246 |
|
| 2019 |
Thomas-Orogan O, Kwok A, Simons A, Judge E, Daly R, Jeyabalan A, Plummeridge M, Spencer L, Barratt S, Adamali H, Medford A. S87 2-year follow up of patients with incidental findings of thoracic lymph-nodal non-caseating granulomas Thorax. 74. DOI: 10.1136/Thorax-2019-Btsabstracts2019.93 |
0.243 |
|
| 2001 |
Crocker IP, Barratt S, Kaur M, Baker PN. The In-Vitro Characterization of Induced Apoptosis in Placental Cytotrophoblasts and Syncytiotrophoblasts Placenta. 22: 822-830. PMID 11718569 DOI: 10.1053/Plac.2001.0733 |
0.243 |
|
| 2009 |
Barratt S, Burn PR, Stone R. Osseous sarcoidosis masquerading as metastatic disease. British Journal of Hospital Medicine (London, England : 2005). 70: 164-5. PMID 19274009 DOI: 10.12968/Hmed.2009.70.3.40572 |
0.239 |
|
| 2017 |
Walker S, Barratt S, Thompson J, Maskell N. S132 Conservative management in traumatic pneumothoraces: an observational study Thorax. 72. DOI: 10.1136/Thoraxjnl-2017-210983.138 |
0.236 |
|
| 2017 |
Walker S, Barratt S, Maskell N, Thompson J. The role of conservative management in traumatic pneumothoraces: an observational study European Respiratory Journal. DOI: 10.1183/1393003.Congress-2017.Oa294 |
0.231 |
|
| 2009 |
Barratt S, Kendrick A, Buchanan F, Whittle A. Central hypoventilation with PHOX2B expansion mutation presenting in adulthood. Bmj Case Reports. 2009. PMID 21686548 DOI: 10.1136/Thx.2006.068908 |
0.211 |
|
| 2018 |
Barratt SL, Creamer A, Hayton C, Chaudhuri N. Idiopathic Pulmonary Fibrosis (IPF): An Overview. Journal of Clinical Medicine. 7. PMID 30082599 DOI: 10.3390/jcm7080201 |
0.188 |
|
| 2007 |
Barratt S, Puthucheary ZA, Plummeridge M. Complete regression of a thymoma to glucocorticoids, commenced for palliation of symptoms. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 31: 1142-3. PMID 17408959 DOI: 10.1016/J.Ejcts.2007.02.032 |
0.188 |
|
| 2010 |
Barratt S, Bateman K, Harvey J. Master of science in medical leadership and management and its role in the current NHS. Clinical Medicine (London, England). 10: 477-9. PMID 21117382 DOI: 10.7861/Clinmedicine.10-5-477 |
0.182 |
|
| 2024 |
Dixon G, Hague S, Mulholland S, Adamali H, Khin AMN, Thould H, Connon R, Minnis P, Murtagh E, Khan F, Toor S, Lawrence A, Naqvi M, West A, Coker RK, ... ... Barratt SL, et al. Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK. Erj Open Research. 10. PMID 38226064 DOI: 10.1183/23120541.00529-2023 |
0.161 |
|
| 2021 |
Roofeh D, Barratt SL, Wells AU, Kawano-Dourado L, Tashkin D, Strand V, Seibold J, Proudman S, Brown KK, Dellaripa PF, Doyle T, Leonard T, Matteson EL, Oddis CV, Solomon JJ, et al. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process. Seminars in Arthritis and Rheumatism. PMID 34493396 DOI: 10.1016/j.semarthrit.2021.08.001 |
0.16 |
|
| 2023 |
Dixon G, Adamali I, Adamali H, Barratt S, Gunarwardena H, Pauling JD. Pharmacological management of systemic sclerosis associated interstitial lung disease. Expert Opinion On Pharmacotherapy. 24: 815-824. PMID 37029594 DOI: 10.1080/14656566.2023.2198640 |
0.156 |
|
| 2020 |
Zulfikar S, Mulholland S, Adamali H, Barratt SL. Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives. Clinical Pharmacology : Advances and Applications. 12: 97-108. PMID 32765123 DOI: 10.2147/CPAA.S228362 |
0.156 |
|
| 2020 |
Creamer AW, Barratt SL. Prognostic factors in chronic hypersensitivity pneumonitis. European Respiratory Review : An Official Journal of the European Respiratory Society. 29. PMID 32414744 DOI: 10.1183/16000617.0167-2019 |
0.156 |
|
| 2022 |
Wells M, Alawi S, Thin KYM, Gunawardena H, Brown AR, Edey A, Pauling JD, Barratt SL, Adamali HI. A multidisciplinary approach to the diagnosis of antisynthetase syndrome. Frontiers in Medicine. 9: 959653. PMID 36186825 DOI: 10.3389/fmed.2022.959653 |
0.151 |
|
| 2021 |
Simpson T, Barratt SL, Beirne P, Chaudhuri N, Crawshaw A, Crowley LE, Fletcher S, Gibbons MA, Hallchurch P, Horgan L, Jakaityte I, Lewis T, McLellan T, Myall KJ, Miller R, et al. The burden of Progressive Fibrotic Interstitial lung disease across the UK. The European Respiratory Journal. PMID 33678609 DOI: 10.1183/13993003.00221-2021 |
0.147 |
|
| 2023 |
Raman L, Stewart I, Barratt SL, Chua F, Chaudhuri N, Crawshaw A, Gibbons M, Hogben C, Hoyles R, Kouranos V, Martinovic J, Mulholland S, Myall KJ, Naqvi M, Renzoni EA, et al. Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study. Erj Open Research. 9. PMID 36949962 DOI: 10.1183/23120541.00423-2022 |
0.143 |
|
| 2021 |
Barratt SL, Adamali HH, Cotton C, Mulhearn B, Iftikhar H, Pauling JD, Spencer L, Adamali HI, Gunawardena H. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services. Bmj Open Respiratory Research. 8. PMID 33419741 DOI: 10.1136/bmjresp-2020-000829 |
0.141 |
|
| 2023 |
Williams RL, Hyams C, Robertshaw J, Gonzalez MG, Szasz-Benczur Z, White P, Maskell NA, Finn A, Barratt SL. Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration. Respiratory Medicine. 107220. PMID 36997098 DOI: 10.1016/j.rmed.2023.107220 |
0.138 |
|
| 2018 |
Barratt SL, Shaw J, Jones R, Bibby A, Adamali H, Mustfa N, Cliff I, Stone H, Chaudhuri N. Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD). Respiratory Medicine. 135: 51-56. PMID 29414453 DOI: 10.1016/j.rmed.2017.12.015 |
0.135 |
|
| 2020 |
George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, Gibbons MA, Hart N, Jenkins RG, McAuley DF, Patel BV, Thwaite E, Spencer LG. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. PMID 32839287 DOI: 10.1136/thoraxjnl-2020-215314 |
0.133 |
|
| 2020 |
Drake TM, Docherty AB, Harrison EM, Quint JK, Adamali H, Agnew S, Babu S, Barber CM, Barratt S, Bendstrup E, Bianchi S, Castillo Villegas D, Chaudhuri N, Chua F, Coker R, et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study. American Journal of Respiratory and Critical Care Medicine. PMID 33007173 DOI: 10.1164/rccm.202007-2794OC |
0.129 |
|
| 2021 |
Lyon M, Whiteway A, Darby M, Bhatt N, Barratt SL. The not so innocent bystander: an unusual cause of progressive breathlessness. Thorax. PMID 33479041 DOI: 10.1136/thoraxjnl-2020-216290 |
0.127 |
|
| 2020 |
Barratt SL, Davis R, Sharp C, Pauling JD. The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review. Erj Open Research. 6. PMID 32832530 DOI: 10.1183/23120541.00027-2020 |
0.127 |
|
| 2022 |
Stewart I, Jacob J, George PM, Molyneaux PL, Porter JC, Allen RJ, Aslani S, Baillie JK, Barratt SL, Beirne P, Bianchi SM, Blaikley JF, Chalmers JD, Chambers RC, Chaudhuri N, et al. Residual Lung Abnormalities Following COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID Study. American Journal of Respiratory and Critical Care Medicine. PMID 36457159 DOI: 10.1164/rccm.202203-0564OC |
0.124 |
|
| 2021 |
Barratt SL, Creamer AW, Adamali HI, Duckworth A, Fallon J, Fidan S, Nancarrow T, Wollerton R, Steward M, Gooptu B, Gibbons M, Woodhead FA, Scotton C. Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study. Bmj Open Respiratory Research. 8. PMID 34794958 DOI: 10.1136/bmjresp-2021-001063 |
0.124 |
|
| 2021 |
Wild JM, Porter JC, Molyneaux PL, George PM, Stewart I, Allen RJ, Aul R, Baillie JK, Barratt SL, Beirne P, Bianchi SM, Blaikley JF, Brooke J, Chaudhuri N, Collier G, et al. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). Bmj Open Respiratory Research. 8. PMID 34556492 DOI: 10.1136/bmjresp-2021-001049 |
0.122 |
|
| 2022 |
Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, ... ... Barratt SL, et al. Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease. Rheumatology (Oxford, England). PMID 36173318 DOI: 10.1093/rheumatology/keac557 |
0.121 |
|
| 2024 |
Tansley SL, McMorrow F, Cotton CV, Adamali H, Barratt SL, Betteridge ZE, Perurena-Prieto J, Gibbons MA, Kular R, Loganathan A, Lamb JA, Lu H, New RP, Pratt D, Rivera-Ortega P, et al. Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung disease. Clinical Immunology (Orlando, Fla.). 110201. PMID 38575043 DOI: 10.1016/j.clim.2024.110201 |
0.12 |
|
| 2024 |
Thomas-Orogan O, Barratt SL, Zafran M, Kwok A, Simons A, Judge EP, Wells M, Daly R, Sharp C, Jeyabalan A, Plummeridge M, Chandratreya L, Spencer LG, Medford ARL, Adamali HI. A Retrospective Analysis of 2-Year Follow-Up of Patients with Incidental Findings of Sarcoidosis. Diagnostics (Basel, Switzerland). 14. PMID 38337753 DOI: 10.3390/diagnostics14030237 |
0.119 |
|
| 2024 |
Harding S, Williams L, Smith N, Soomro DES, Allawi S, Singh K, Chowdhury M, Deogan V, Staples A, Leung N, Srivastava S, Adamali H, Barratt SL. Animal-derived medicinal products: community representatives' views of their use. Future Healthcare Journal. 10: 291-295. PMID 38162195 DOI: 10.7861/fhj.2023-0005 |
0.114 |
|
| 2021 |
Barratt SL, Robertshaw J, Campbell H, Clarke E. Rare case of multisystem sarcoidosis. Bmj Case Reports. 14. PMID 33753388 DOI: 10.1136/bcr-2020-240825 |
0.114 |
|
| 2021 |
Arnold DT, Donald C, Lyon M, Hamilton FW, Morley AJ, Attwood M, Dipper A, Barratt SL. Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks. Plos One. 16: e0249607. PMID 33914762 DOI: 10.1371/journal.pone.0249607 |
0.107 |
|
| 2019 |
Creamer AW, Barratt SL. Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial. Breathe (Sheffield, England). 15: 140-143. PMID 31191728 DOI: 10.1183/20734735.0002-2019 |
0.101 |
|
| 2018 |
Barratt SL, Mulholland S, Al Jbour K, Steer H, Gutsche M, Foley N, Srivastava R, Sharp C, Adamali HI. South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). Frontiers in Pharmacology. 9: 1480. PMID 30618768 DOI: 10.3389/fphar.2018.01480 |
0.101 |
|
| 2022 |
Mikolasch TA, George PM, Sahota J, Nancarrow T, Barratt SL, Woodhead FA, Kouranos V, Cope VSA, Creamer AW, Fidan S, Ganeshan B, Hoy L, Mackintosh JA, Shortman R, Duckworth A, et al. Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis. Eclinicalmedicine. 55: 101758. PMID 36483266 DOI: 10.1016/j.eclinm.2022.101758 |
0.1 |
|
| 2018 |
Barratt SL, Morales M, Spiers T, Al Jboor K, Lamb H, Mulholland S, Edwards A, Gunary R, Meek P, Jordan N, Sharp C, Kendall C, Adamali HI. Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs. Bmj Open Respiratory Research. 5: e000360. PMID 30622718 DOI: 10.1136/bmjresp-2018-000360 |
0.096 |
|
| 2024 |
Smith N, Williams L, Harding S, Singh K, Soomro DES, Alawi S, Chowdhury M, Deogan V, Parker E, Henson A, Easton F, Leung N, Staples A, Srivastava S, Adamali H, ... Barratt SL, et al. Factoring patients' beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement project. Future Healthcare Journal. 10: 301-305. PMID 38162220 DOI: 10.7861/fhj.2023-0034 |
0.089 |
|
| 2020 |
Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, ... ... Barratt SL, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. PMID 33273026 DOI: 10.1136/thoraxjnl-2020-216086 |
0.084 |
|
| 2021 |
Speirs TP, Tuffin N, Mundy-Baird F, Sakota H, Mulholland S, Westlake M, Lyon M, Medford AR, Sharp C, Darby M, Albur M, Keeley F, Burden H, Kenward C, Jonas E, ... Barratt S, et al. Long-term nitrofurantoin: analysis of complication awareness, monitoring and pulmonary injury cases. Bjgp Open. PMID 34407964 DOI: 10.3399/BJGPO.2021.0083 |
0.072 |
|
| 2023 |
Lu-Song J, Bakal JA, Younus S, Moran-Mendoza O, Harle I, Morales M, Rippon N, Barratt SL, Adamali H, Kalluri M. The Impact of Integrated Palliative Care on Survival in Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Comparison. The American Journal of Hospice & Palliative Care. 10499091231194722. PMID 37553275 DOI: 10.1177/10499091231194722 |
0.069 |
|
| 2017 |
Walker SP, Barratt SL, Thompson J, Maskell NA. Conservative Management in Traumatic Pneumothoraces: An Observational Study. Chest. PMID 29080710 DOI: 10.1016/j.chest.2017.10.015 |
0.069 |
|
| 2001 |
Rowe DJ, Omar H, Barratt SL, Biggs P. An evaluation of blood creatinine measurement by creatinase on the NOVA M7 blood gas analyzer. Clinica Chimica Acta; International Journal of Clinical Chemistry. 307: 23-5. PMID 11369332 DOI: 10.1016/S0009-8981(01)00458-2 |
0.068 |
|
| 2021 |
Arnold DT, Attwood M, Barratt S, Morley A, Elvers KT, McKernon J, Donald C, Oates A, Noel A, MacGowan A, Maskell NA, Hamilton FW. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emergency Medicine Journal : Emj. PMID 34021028 DOI: 10.1136/emermed-2020-210380 |
0.058 |
|
| 2020 |
Flower VA, Barratt SL, Hart DJ, Mackenzie AB, Shipley JA, Ward SG, Pauling JD. High frequency ultrasound assessment of systemic sclerosis skin involvement: intra-observer repeatability and relationship with clinician assessment and dermal collagen content. The Journal of Rheumatology. PMID 33132218 DOI: 10.3899/jrheum.200234 |
0.057 |
|
| 2021 |
Hardacre CJ, Robertshaw JA, Barratt SL, Adams HL, MacKenzie Ross RV, Robinson GR, Suntharalingam J, Pauling JD, Rodrigues JCL. Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review. The British Journal of Radiology. 20210332. PMID 34541861 DOI: 10.1259/bjr.20210332 |
0.049 |
|
| 2019 |
Davidson J, McErlane J, Jboor KA, Barratt SL, Jeyabalan A, Medford ARL, Borman AM, Adamali H. To blow one's trumpet - a musical composition that fits the mould. A case report of Purpureocillium lilacinum causing hypersensitivity pneumonitis in a tenor horn player. Qjm : Monthly Journal of the Association of Physicians. PMID 30649525 DOI: 10.1093/qjmed/hcz020 |
0.029 |
|
| 2018 |
Creamer AW, Protheroe R, Gunawardena H, Barratt SL. Pancytopaenia and breathlessness: Hickam's Dictum prevails! Thorax. PMID 30121573 DOI: 10.1136/thoraxjnl-2018-212088 |
0.01 |
|
| Hide low-probability matches. |